LY-255582
LY-255582 is a potent opioid receptor antagonist that has been studied for its potential therapeutic applications. It is a synthetic compound that interacts with the opioid receptor system in the brain and other parts of the body.
Pharmacology
LY-255582 acts primarily as an antagonist at the mu-opioid receptor (MOR), delta-opioid receptor (DOR), and kappa-opioid receptor (KOR). By blocking these receptors, LY-255582 can inhibit the effects of endogenous opioids and opioid drugs. This makes it a potential candidate for the treatment of opioid addiction and opioid overdose.
Mechanism of Action
The mechanism of action of LY-255582 involves its binding to the opioid receptors, preventing the activation of these receptors by endogenous ligands such as endorphins and enkephalins, as well as exogenous opioid drugs like morphine and heroin. This blockade can reduce the euphoric and analgesic effects of opioids, which is beneficial in treating addiction and overdose.
Therapeutic Applications
LY-255582 has been investigated for several therapeutic applications, including:
- Opioid addiction: By blocking the effects of opioids, LY-255582 may help in reducing cravings and withdrawal symptoms in individuals addicted to opioids.
- Opioid overdose: As an opioid receptor antagonist, LY-255582 can be used to reverse the life-threatening effects of opioid overdose, similar to naloxone.
- Pain management: Although primarily an antagonist, LY-255582's interaction with the opioid system may have implications for pain management, particularly in reducing opioid tolerance and dependence.
Research and Development
Research on LY-255582 is ongoing, with studies focusing on its efficacy, safety, and potential side effects. Clinical trials are necessary to fully understand its therapeutic potential and to determine the appropriate dosing regimens.
See Also
References
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
